Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Update Il y a 4 ans
Reference: NCT00435448

Extract

The purpose of this study is to evaluate the efficacy of lonidamine (50mg, 150mg) compared to placebo in subjects with symptomatic BPH.


Inclusion criteria

  • benign prostatic hyperplasia ,Enlarged prostate


Links